Clinical Trial Update: Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating how patiromer affects the pharmacokinetics of immunosuppressive drugs in kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia
• Kidney Transplant Complications

Drugs mentioned

• Patiromer (patiromer)

Snippet

Sponsor: Oslo University Hospital | Conditions: Hyperkalemia, Kidney Transplant | Phase 4 | Status: COMPLETED